Table 1. Nationwide surveys on the prevalence of hypertension in China.
| Study name | Time | Age, yrs | Sampling method | Sample size | Prevalence, % |
| Key project of Chinese Academy of Medical Sciences-hypertension research |
1958–1959 | ≥ 15 | Non-random | 739,204 | 5.1 |
| National hypertension sampling survey | 1979–1980 | ≥ 15 | Random | 4,012,128 | 7.7 |
| National hypertension sampling survey | 1991 | ≥ 15 | Stratified random | 950,356 | 13.6 |
| China Health and Nutrition Survey | 2002 | ≥ 18 | Multistage stratified cluster random sampling |
272,023 | 18.8 |
| Survey on the Status of Nutrition and Chronic Diseases of Chinese Residents |
2012 | ≥ 18 | Multistage stratified random | – | 25.2 |
| China Hypertension Survey | 2012–2015 | ≥ 18 | Multistage stratified random | 451,755 | 27.9 (Weighted 23.2) |
| China Health and Nutrition Survey | 2015 | 20–79 | Multistage stratified cluster random | 8907 | 34.1 (Standardized 25.6) |
| China Chronic Disease and Risk Factor Surveillance | 2018 | ≥ 18 | Multistage stratified cluster random | 179,873 | 27.5 (Weighted) |